32 research outputs found
Multigene assays and molecular markers in breast cancer: systematic review of health economic analyses
Get PDFTreatment decisions in estrogen receptor-positive early breast cancer patients with intermediate oncotype DX recurrence score results
Get PDFPCN20 REAL LIFE TREATMENT DURATION OF SORAFENIB OR SUNITINIB IN FIRST LINE METASTATIC RENAL CELL CARCINOMA PATIENTS— A COMPARATIVE ANALYSIS
No full textPCN55 THE IMPACT OF 21-GENE RT-PCRASSAY ON REAL LIFE TREATMENT DECISIONS IN N−, ER+ EARLY-STAGE BREAST CANCER PATIENTS: IT'S IMPLICATION FOR BUDGET IMPACT ANALYSIS
No full text
PMS27 COST CONSEQUENCE ANALYSIS OF RITUXIMAB TREATMENT FOR RHEUMATOID ARTHRITIS IN ISRAEL
No full textPIN78 DIRECT MONTHLY HAART SUPPLY AT THE AIDS CENTER—A COST-EFFECTIVE MODE TO INCREASE ADHERENCE AND OUTCOME
No full textThe impact of the 21-gene Recurrence Score assay on clinical decision-making in node-positive (up to 3 positive nodes) estrogen receptor-positive breast cancer patients
No full text
Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry
No full text
